Investors Strapped Rocket Corcept: Why the Stock Jumped on Wednesday
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Overview of a yearly tax planning approach for index fund losses, detailing steps to track opportunities, document losses, and optimize filings.
19,656 articlesA pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Titan America (TTAM) is shaping investor expectations in 2026 as Q1 results roll in. This deep dive translates earnin...
A timely tribute to Ted Turner and the daring moves that built a media empire. From billboard prince to cable mogul, ...
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
The Department of Homeland Security is requesting $7.5 million to develop wearable facial-recognition glasses for ICE...
As the first quarter of 2026 unfolds, invivyd ivvd 2026 earnings take center stage for investors watching the biotech...
A cross-chain breach targeting the Verus-Ethereum bridge drained more than $11 million, triggering renewed focus on s...
The 30-year treasury just crossed 5%, triggering a rotation from growth into asset-backed champions. This article fla...
After a dramatic surge, investors want to know if Iren stock still after the rally makes sense. This article breaks d...
Orbital Industries closes a $50 million Series B to accelerate AI-powered materials discovery and move toward selling...
Primerica's earnings trajectory hinges on policy sales, investment product performance, and agent distribution. This ...
When markets wobble, the strength of a company’s balance sheet and its cash runway often beat a glossy business story...